REBECCA ADCOCK: Open Payments
NPI 1821687187 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 17 payments from 9 companies in 2025. Trend: 2023 $712 · 2024 $517 · 2025 $373
Food & beverage: $304Education: $69
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $157 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Dexcom, Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| MILLICENT US INC | 1 | $20 |
| Organon LLC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $11 |
Products named: Veozah, INJECTAFER, Dexcom G6 Transmitter, MYFEMBREE, FEMRING, NEXPLANON, Paragard T 380A, Mirena.
Industry payments across LA — which companies pay providers there.
